2018 | Safety and immunogenicity of an upper-range release titer measles-mumps-rubella vaccine in children vaccinated at 12 to 15 months of age: a phase III, randomized study | Gregory A.; Anitta A.; Andrea B.; Archana C.; Nan-Chang C.; Clemente D.P.; Byron H.; LI-MIN HUANG ; Robert J.; Nicola K.; Michael L.; Ming-Chih L.; Marita P.; Kwabena S.; Peter S.; Jerry T.; Timo V.; Leonard W.; Tsung Zu W.; Stephane C.; Christophe D.; Michael P.; Remon A.-E.; Ouzama H.; Carmen B. | Human Vaccines and Immunotherapeutics | 8 | 5 | |